jatrorrhizine has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Gong, W; Hou, X; Huang, L; Li, C; Liang, W; Mo, C; Ou, M; Sha, Y | 1 |
| Dian, LL; Gao, XY; Liang, ZS; Phyo, AT; Qasim, M; Sun, YF; Sun, ZX; Wang, P; Yang, SQ | 1 |
2 other study(ies) available for jatrorrhizine and Colorectal Cancer
| Article | Year |
|---|---|
High-throughput sequencing reveals Jatrorrhizine inhibits colorectal cancer growth by ferroptosis-related genes.
Topics: Apoptosis; Colorectal Neoplasms; Ferroptosis; High-Throughput Nucleotide Sequencing; Humans | 2023 |
Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Topics: Animals; Antineoplastic Agents; Apoptosis; Berberine; beta Catenin; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; HCT116 Cells; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Structure-Activity Relationship; Wnt Signaling Pathway; Wound Healing | 2019 |